Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ABTX - Agribiotech -- Ignore unavailable to you. Want to Upgrade?

To: W Shakespeare who wrote (7598)	2/24/1999 10:15:00 PM
From: Richard Richardson	Respond to of 8359

Annual Meeting Notes/Opinions I have been a shareholder since December, 1996 and have attended the last three annual meetings. There is no substitute for attending the annual meeting. This latest meeting was EXTREMELY positive in my view. The company is very focused and continues to make tremendous progress with their business plan. Attendees were civil and engaged with absolutely no evidence of hostility toward management. The reports from Bloomberg concerning the meeting, in my opinion, were extremely slanted. My cousin, who is a broker, attended the meeting and was very favorably surprised by ABTX and couldn't believe this was the same company that Bloomberg continually tried to downplay. Had a long talk with Barry Summermour from Stephens who was also favorably impressed. Had a breakfast meeting with JT and continue to be amazed by the vision, focus, work ethic, honesty, and CREDIBILITY that this man demonstrates. This is the third time I have had a chance to talk with him at length and each time I understand exactly why I have invested so heavily in ABTX. I am now more convinced than ever that the value he helped to create will be appreciated greatly by shareholders in the months/years to come. He was SCREWED for expressing his true opinions about the value of ABTX and for not suffering fools well. I know very little compared to JT about ABTX, but even I am continually amazed by the moronic questions/accusations he has to endure. There is no question, in my mind, that several bids ($19 to $31) were going to be evaluated by ABTX at a formal meeting but were suspended when the lawsuit hit. Bloomberg tries to suggest that there was no interest in ABTX by the MACC's. That is CLEARLY WRONG! It was apparently very difficult to value ABTX in the defined four-month time period because of the multiple accounting systems of the acquired companies and therefore the MACC's bid on the low end of the range because of the uncertainty of the valuation. I am now convinced that the deal suspension was in our best interest since the valuations will be significantly higher once the integration is complete and positive earnings are reported. Finally, Tom Rice stated that there is no inherent reason why forage/turf biotech innovations would take longer than other crops. PERIOD. In addition, JT stated that any redundant seed facilities that are sold will have restrictions placed so no potential competitors can use them. GREAT MEETING. GREAT COMPANY.

To: W Shakespeare who wrote (7598)	2/25/1999 7:50:00 AM
From: BioInv	Respond to of 8359

I also listened to the call. Agree with your comments and add the following. 1 Ingram indicated that lack of cash should not be a potential problem until the latter part of the summer. 2 No more acquisitions without funding in place. Ingram was pushed on this issue by one analyst. 3 The analyst's questions indicated concerns with a the 'four headed' decision making approach in the President's office b the slow pace of the integration and c the need to improve relationships with Wall Street.